• Is Adaptimmune Therapeutics plc (Common Stock) (473A) stock a buy before new product rollout - July 2025 Fed Impact & High Accurac... newser.com Fri, 03 Oct 2025 10:36:45 GMT
• Can Adaptimmune Therapeutics plc (Common Stock) (473A) stock sustain breakout momentum - CPI Data & Community Consensus Stock Pick... newser.com Fri, 03 Oct 2025 09:23:10 GMT
• How Adaptimmune Therapeutics plc (Common Stock) (473A) stock reacts to Fed tightening - July 2025 Recap & Community Verified Trade... newser.com Fri, 03 Oct 2025 02:20:23 GMT
• what analysts say about adaptimmune therapeutics plc common stock 473a stock - stock rotation strategies & affordable market strat... earlytimes.in Wed, 01 Oct 2025 17:39:33 GMT
• How Adaptimmune Therapeutics plc (Common Stock) (473A) stock reacts to Fed tightening - Portfolio Performance Summary & Short-Term... newser.com Tue, 30 Sep 2025 10:28:17 GMT
• can adaptimmune therapeutics plc (common stock) (473a) stock beat analyst consensus - market movers & ai based trade execution ale... newser.com Tue, 30 Sep 2025 07:51:13 GMT
• What drives Adaptimmune Therapeutics plc Common Stock 473A stock price - Mean Reversion Trades & Swing Trade Smarter With Data Ins... earlytimes.in Tue, 30 Sep 2025 05:13:51 GMT
• Is Adaptimmune Therapeutics plc (Common Stock) (473A) stock a buy before new product rollout - Market Risk Report & Real-Time Volu... newser.com Mon, 29 Sep 2025 14:16:00 GMT
• How Adaptimmune Therapeutics plc (Common Stock) (473A) stock reacts to weak economy - 2025 Macro Impact & Real-Time Volume Analysi... newser.com Mon, 29 Sep 2025 07:43:53 GMT
• Can Adaptimmune Therapeutics plc (Common Stock) (473A) stock sustain breakout momentum - July 2025 Trends & Safe Entry Zone Tips newser.com Mon, 29 Sep 2025 04:31:47 GMT
• Can Adaptimmune Therapeutics plc (Common Stock) (473A) stock beat analyst consensus - 2025 Dividend Review & Community Consensus T... newser.com Sun, 28 Sep 2025 09:22:13 GMT
• Adaptimmune Granted Exception Period by Nasdaq Panel The Globe and Mail Sat, 27 Sep 2025 21:12:00 GMT
• can adaptimmune therapeutics plc (common stock) (473a) stock beat analyst consensus - earnings performance report & fast entry mom... newser.com Sat, 27 Sep 2025 16:34:18 GMT
• How Adaptimmune Therapeutics plc (Common Stock) (473A) stock reacts to Fed tightening - 2025 Geopolitical Influence & Low Risk Ent... newser.com Fri, 26 Sep 2025 17:05:56 GMT
• adaptimmune therapeutics plc(nasdaqcm: adap) dropped from s&p global bmi index MarketScreener Mon, 22 Sep 2025 01:08:50 GMT
• Adaptimmune Therapeutics plc(NasdaqCM: ADAP) dropped from S&P Global BMI Index MarketScreener Sun, 21 Sep 2025 07:00:00 GMT
• Why FedEx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket Benzinga Fri, 19 Sep 2025 07:00:00 GMT
• Adaptimmune Therapeutics Stock (ADAP) Rockets 50% on CCO Severance Agreement MSN Wed, 17 Sep 2025 10:13:30 GMT
• Biotech And Medtech Stocks Rally After-Hours Across Key Names RTTNews Mon, 15 Sep 2025 07:00:00 GMT
• adaptimmune faces nasdaq delisting notice for low market value TipRanks Sat, 13 Sep 2025 07:11:30 GMT
• Adaptimmune Faces Nasdaq Delisting Notice for Low Market Value TipRanks Fri, 12 Sep 2025 07:00:00 GMT
• layoff tracker: merck to cut 125 employees as it ends uk r&d work BioSpace Fri, 12 Sep 2025 07:00:00 GMT
• layoff tracker: novo cuts 9,000 employees, including 5,000 in denmark BioSpace Fri, 05 Sep 2025 07:00:00 GMT
• adaptimmune therapeutics cfo wood sells $950 in shares Investing.com India Thu, 04 Sep 2025 02:31:30 GMT
• adaptimmune cfo wood gavin sells 96k shares at $0.01/sh on 2025-09-02 AInvest Wed, 03 Sep 2025 21:17:04 GMT
• Adaptimmune Therapeutics CFO Wood sells $950 in shares Investing.com Wed, 03 Sep 2025 07:00:00 GMT
• layoff tracker: novartis continues cutting spree with 58 sacked in new jersey BioSpace Wed, 03 Sep 2025 07:00:00 GMT
• adaptimmune therapeutics coo bertrand c jr sells 207k shares at $0.01/share. AInvest Fri, 29 Aug 2025 22:31:05 GMT
• Adaptimmune Announces Executive Team Changes Amid Restructuring TipRanks Fri, 29 Aug 2025 07:00:00 GMT
• layoff tracker: novartis continues cutting spree with 58 sacked in new jersey BioSpace Fri, 29 Aug 2025 07:00:00 GMT
• layoff tracker: exelixis cuts go beyond pennsylvania, include 71 at california hq BioSpace Fri, 29 Aug 2025 07:00:00 GMT
• adaptimmune therapeutics stock (adap) rockets 50% on cco severance agreement MSN Thu, 28 Aug 2025 14:16:42 GMT
• 🚀 are there any significant product launches or developments from adap in the near future? AInvest Mon, 25 Aug 2025 07:00:00 GMT
• a navy yard biotech is selling its first-of-its-kind therapy for rare cancer, along with other assets MSN Fri, 22 Aug 2025 17:21:42 GMT
• Earnings call transcript: Adaptimmune Q2 2025 shows revenue beat, stock dips Investing.com Thu, 21 Aug 2025 07:00:00 GMT
• adaptimmune director behbahani sells shares worth $229,171 by investing.com Investing.com South Africa Thu, 21 Aug 2025 02:34:33 GMT
• adaptimmune therapeutics stock (adap) rockets 50% on cco severance agreement MSN Wed, 20 Aug 2025 22:38:12 GMT
• layoff tracker: opthea slashes 80% of workforce, 50% of board BioSpace Wed, 20 Aug 2025 20:48:18 GMT
• Adaptimmune Therapeutics Stock (ADAP) Opinions on Recent Corporate Transactions Quiver Quantitative Wed, 20 Aug 2025 07:00:00 GMT
• adaptimmune director behbahani sells shares worth $229,171 by investing.com Investing.com Australia Wed, 20 Aug 2025 05:57:59 GMT
• director’s major stock sale shakes up adaptimmune therapeutics! TipRanks Wed, 20 Aug 2025 02:09:21 GMT
• Director’s Major Stock Sale Shakes Up Adaptimmune Therapeutics! TipRanks Tue, 19 Aug 2025 07:00:00 GMT
• Adaptimmune director Behbahani sells shares worth $229,171 Investing.com Tue, 19 Aug 2025 07:00:00 GMT
• are there any recent news or announcements that could be contributing to adap's price surge AInvest Tue, 19 Aug 2025 07:00:00 GMT
• adaptimmune surged 58% on earnings—can this biotech stock keep defying gravity? AInvest Tue, 19 Aug 2025 07:00:00 GMT
• Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket Benzinga Mon, 18 Aug 2025 07:00:00 GMT
• Swedish biotech gets $46M to run early TCR cell therapy clinical trial Endpoints News Mon, 18 Aug 2025 07:00:00 GMT
• adaptimmune therapeutics stock (adap) rockets 50% on cco severance agreement TipRanks Mon, 18 Aug 2025 07:00:00 GMT
• genentech ends up to $2b cell therapy collab with adaptive Endpoints News Mon, 18 Aug 2025 07:00:00 GMT
• healthcare stocks move in after-market session: dih holding, tonix pharmaceuticals, bioxcel therapeutics lead gainers, tivic healt... AInvest Sat, 16 Aug 2025 07:00:00 GMT
• adaptimmune therapeutics (adap) gets a sell from barclays The Globe and Mail Fri, 15 Aug 2025 09:00:00 GMT
• Adaptimmune Announces CCO Departure and Severance Agreement TipRanks Fri, 15 Aug 2025 07:00:00 GMT
• adaptimmune faces nasdaq delisting notice amid compliance issues The Globe and Mail Fri, 15 Aug 2025 07:00:00 GMT
• hold rating maintained for adaptimmune therapeutics amid revenue growth and strategic uncertainties TipRanks Fri, 15 Aug 2025 07:00:00 GMT
• layoff tracker: bausch health closes california site, cuts 49 employees BioSpace Fri, 15 Aug 2025 07:00:00 GMT
• Adaptimmune Faces Nasdaq Delisting Notice Amid Compliance Issues TipRanks Thu, 14 Aug 2025 07:00:00 GMT
• cibc asset management inc. announces termination of the cibc 2025 investment grade bond funds The Globe and Mail Wed, 13 Aug 2025 12:30:17 GMT
• Adaptimmune Reports Q2 Financial Results and Provides Business Update Newsfile Wed, 13 Aug 2025 07:00:00 GMT
• Adaptimmune's $55M Cell Therapy Sale Drives Strategic Shift as Tecelra Sales Surge 150% Stock Titan Wed, 13 Aug 2025 07:00:00 GMT
• adaptimmune therapeutics earnings beat by $0.03, revenue topped estimates Investing.com UK Wed, 13 Aug 2025 07:00:00 GMT
• adaptimmune q2 2025 earnings exceed estimates with 59% revenue growth, gaap eps at $(0.02). AInvest Wed, 13 Aug 2025 07:00:00 GMT
• adaptimmune surpasses earnings and revenue expectations in q2, analysts provide mixed outlook AInvest Wed, 13 Aug 2025 07:00:00 GMT
• adaptimmune therapeutics plc reports results for the quarter ended june 30 - earnings summary TradingView Wed, 13 Aug 2025 07:00:00 GMT
• philly’s biotech industry keeps losing local jobs in a volatile market WHYY Tue, 12 Aug 2025 01:36:10 GMT
• adap’s stock market pendulum: swinging between gains and losses investchronicle.com Mon, 11 Aug 2025 15:02:32 GMT
• Philly’s biotech industry keeps losing local jobs in a volatile market WHYY Mon, 11 Aug 2025 07:00:00 GMT
• This Week’s CGT News: Adaptimmune Therapeutics to Restructure After Acquisition The Medicine Maker Mon, 11 Aug 2025 07:00:00 GMT
• layoff tracker: bicycle, tune, iovance, precision downsize to conserve cash BioSpace Sun, 10 Aug 2025 01:41:43 GMT
• adaptimmune therapeutics (adap) to release quarterly earnings on monday Defense World Sat, 09 Aug 2025 05:54:54 GMT
• adaptimmune adap 2025q2 earnings preview upside expected from innovative tcr-t cell therapies AInvest Sat, 09 Aug 2025 00:42:22 GMT
• adaptimmune therapeutics plc expected to post a loss of 10 cents a share - earnings preview TradingView Fri, 08 Aug 2025 22:15:18 GMT
• adaptimmune adap 2025q2 earnings preview upside expected from innovative tcr-t cell therapies AInvest Fri, 08 Aug 2025 07:00:00 GMT
• mcan financial group releases q2 2025 results and declares 41 cents cash dividend The Globe and Mail Thu, 07 Aug 2025 00:35:00 GMT
• US WorldMeds takes over quartet of Adaptimmune cell therapies in $55m deal BioXconomy Wed, 06 Aug 2025 07:00:00 GMT
• adaptimmune therapeutics plc (adap) plunges 10.53% on earnings report AInvest Wed, 06 Aug 2025 07:00:00 GMT
• why palantir technologies shares are trading higher by over 5%; here are 20 stocks moving premarket Benzinga Tue, 05 Aug 2025 07:00:00 GMT
• healthcare stocks rise and fall in tuesday's intraday session AInvest Tue, 05 Aug 2025 07:00:00 GMT
• adaptimmune's 31% surge: restructuring gambit or biotech breakout? AInvest Tue, 05 Aug 2025 07:00:00 GMT
• adaptimmune therapeutics stock soars 54.43% on strategic restructuring AInvest Tue, 05 Aug 2025 07:00:00 GMT
• layoff tracker: sirona liquidates tfchem, merck will cut 6,000 employees BioSpace Mon, 04 Aug 2025 17:03:45 GMT
• US WorldMeds Completes Acquisition of Adaptimmune's Cell-Therapy Portfolio; Ensures Continued Patient Access to Tecelra and Advanc... Yahoo Finance Mon, 04 Aug 2025 07:00:00 GMT
• adaptimmune sells cell therapy assets for $55 million The Globe and Mail Fri, 01 Aug 2025 21:46:00 GMT
• a navy yard biotech is selling its first-of-its-kind therapy for rare cancer, along with other assets MSN Fri, 01 Aug 2025 20:29:53 GMT
• guggenheim downgrades adaptimmune therapeutics(adap.us) to hold rating 富途牛牛 Fri, 01 Aug 2025 11:42:00 GMT
• Novo Nordisk nominates CEO successor—Chutes & Ladders Fierce Biotech Fri, 01 Aug 2025 07:00:00 GMT
• aste director gets 475 share grant; insider holding rises to 8,377 | adap sec filing - form 8-k Stock Titan Thu, 31 Jul 2025 21:02:43 GMT
• ecor1 capital sells adaptimmune therapeutics (adap) shares for $6.89m Investing.com India Thu, 31 Jul 2025 07:00:00 GMT
• major shareholder offloads millions in adaptimmune therapeutics stock! TipRanks Thu, 31 Jul 2025 02:43:41 GMT
• rainbows and unicorns: adaptimmune therapeutics plc (nasdaq:adap) analysts just became a lot more optimistic 富途牛牛 Wed, 30 Jul 2025 20:15:51 GMT
• Major Shareholder Offloads Millions in Adaptimmune Therapeutics Stock! TipRanks Wed, 30 Jul 2025 07:00:00 GMT
• Ecor1 capital sells Adaptimmune Therapeutics (ADAP) shares for $6.89m By Investing.com Investing.com Nigeria Wed, 30 Jul 2025 07:00:00 GMT
• around the helix: cell and gene therapy company updates – july 30, 2025 CGTLive® Wed, 30 Jul 2025 07:00:00 GMT
• adaptimmune therapeutics: ecor1 capital sells shares at $0.1 to $0.11 each. AInvest Wed, 30 Jul 2025 07:00:00 GMT
• hold rating maintained for adaptimmune therapeutics amid strategic asset sale and leadership changes TipRanks Wed, 30 Jul 2025 07:00:00 GMT
• adaptimmune sells off cell therapies in deal worth up to $85 million to address solvency concerns AInvest Wed, 30 Jul 2025 03:56:03 GMT
• mizuho securities sticks to its hold rating for adaptimmune therapeutics (adap) The Globe and Mail Tue, 29 Jul 2025 17:44:00 GMT
• a navy yard biotech is selling its first-of-its-kind therapy for rare cancer, along with other assets MSN Tue, 29 Jul 2025 17:23:38 GMT
• quantum biopharma shares rise 1.49% premarket after adaptimmune's deal with us worldmeds. AInvest Tue, 29 Jul 2025 11:23:14 GMT
• Adaptimmune Therapeutics (ADAP) Receives Downgrade from HC Wainw GuruFocus Tue, 29 Jul 2025 07:00:00 GMT
• analysts not impressed with adaptimmune’s survival attempts insights.citeline.com Tue, 29 Jul 2025 07:00:00 GMT
• adaptimmune stock rating downgraded by h.c. wainwright after asset sale Investing.com Tue, 29 Jul 2025 07:00:00 GMT
• this albemarle analyst turns bearish; here are top 5 downgrades for tuesday Benzinga Tue, 29 Jul 2025 07:00:00 GMT
• is there any plans for reverse stock split on adaptimmune therapeutics? AInvest Tue, 29 Jul 2025 07:00:00 GMT
• adaptimmune (nasdaq: adap) plunges 71.17% to record low as $55m cell therapy sale drives strategic shift to development-stage AInvest Tue, 29 Jul 2025 07:00:00 GMT
• adaptimmune therapeutics downgraded to neutral following asset sale and financial concerns AInvest Tue, 29 Jul 2025 07:00:00 GMT
• adaptimmune therapeutics (adap) downgraded by hc wainwright & co. AInvest Tue, 29 Jul 2025 07:00:00 GMT
• adaptimmune therapeutics shares rise 12% premarket after announcing a $85 million sale of cell therapy programs to us worldmeds. AInvest Tue, 29 Jul 2025 07:00:00 GMT
• adaptimmune: hc wainwright downgrades neutral to buy rating, no reason given. AInvest Tue, 29 Jul 2025 07:00:00 GMT
• adaptimmune sells off cell therapies in deal worth up to $85 million to address solvency concerns AInvest Tue, 29 Jul 2025 07:00:00 GMT
• mizuho securities maintains adaptimmune therapeutics(adap.us) with hold rating, maintains target price $0.5 富途牛牛 Mon, 28 Jul 2025 21:36:53 GMT
• Adaptimmune sells 4 cell therapies to pharma for $55M, plans layoffs Fierce Biotech Mon, 28 Jul 2025 07:00:00 GMT
• Adaptimmune sells off cell therapies to stay afloat, but its stock sinks FirstWord Pharma Mon, 28 Jul 2025 07:00:00 GMT
• Adaptimmune Therapeutics stock plunges after selling cell therapy assets Investing.com Mon, 28 Jul 2025 07:00:00 GMT
• Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US Wo... Newsfile Mon, 28 Jul 2025 07:00:00 GMT
• Adaptimmune's Groundbreaking Cell Therapy Assets Acquired by US WorldMeds in $85M Strategic Deal Stock Titan Mon, 28 Jul 2025 07:00:00 GMT
• Adaptimmune, seeking to stay afloat, sells off cell therapies BioPharma Dive Mon, 28 Jul 2025 07:00:00 GMT
• Adaptimmune sells cell therapy assets to US WorldMeds for $55 million Investing.com Mon, 28 Jul 2025 07:00:00 GMT
• Adaptimmune to slash workforce, sell key assets to US WorldMeds for $55 million The Business Journals Mon, 28 Jul 2025 07:00:00 GMT
• us stocks mixed; enterprise products partners posts upbeat earnings Benzinga Mon, 28 Jul 2025 07:00:00 GMT
• adaptimmune sells cell therapy assets to mdd us operations for $55m AInvest Mon, 28 Jul 2025 07:00:00 GMT
• adaptimmune to sell cell therapy portfolio to us worldmeds for $55 million plus milestones AInvest Mon, 28 Jul 2025 07:00:00 GMT
• adaptimmune announces sale of cell therapies to us worldmeds, retains preclinical assets AInvest Mon, 28 Jul 2025 07:00:00 GMT
• adaptimmune therapeutics shares rise 17% after-hours after announcing a $85 million sale of cell therapy programs to us worldmeds.... AInvest Mon, 28 Jul 2025 07:00:00 GMT
• a navy yard biotech is selling its first-of-its-kind therapy for rare cancer, along with other assets Inquirer.com Mon, 28 Jul 2025 07:00:00 GMT
• adaptimmune settles litigation with m.d. anderson cancer center The Globe and Mail Fri, 18 Jul 2025 07:00:00 GMT
• Adaptimmune Settles Litigation with M.D. Anderson Cancer Center TipRanks Thu, 17 Jul 2025 07:00:00 GMT
• adaptimmune settles litigation with m.d. anderson cancer center TipRanks Wed, 16 Jul 2025 07:00:00 GMT
• mizuho downgrades adaptimmune therapeutics plc - depositary receipt () (adap) MSN Mon, 07 Jul 2025 05:46:23 GMT
• mizuho downgrades adaptimmune therapeutics plc - depositary receipt () (adap) MSN Fri, 27 Jun 2025 09:07:23 GMT
• adap stock downgraded by mizuho: price target slashed by 66% | a GuruFocus Thu, 26 Jun 2025 15:18:42 GMT
• mizuho downgrades adaptimmune therapeutics to neutral from outperform, cuts price target to $0.50 from $1.50 on solvency concerns MarketScreener Thu, 26 Jun 2025 10:31:15 GMT
• Adaptimmune (ADAP) Downgraded Amid Solvency Concerns | ADAP Stoc GuruFocus Thu, 26 Jun 2025 07:00:00 GMT
• this trade desk analyst is no longer bullish; here are top 5 downgrades for thursday Benzinga Thu, 26 Jun 2025 07:00:00 GMT
• mizuho downgrades adaptimmune therapeutics plc - depositary receipt () (adap) MSN Thu, 26 Jun 2025 07:00:00 GMT
• mizuho downgrades adaptimmune to neutral on solvency concerns TipRanks Wed, 25 Jun 2025 20:32:34 GMT
• Mizuho downgrades Adaptimmune stock on solvency concerns Investing.com Wed, 25 Jun 2025 07:00:00 GMT
• Adaptimmune (ADAP) Downgraded by Mizuho Due to Financial Concerns | ADAP Stock News GuruFocus Wed, 25 Jun 2025 07:00:00 GMT
• adaptimmune (adap) downgraded by mizuho with revised price targe GuruFocus Wed, 25 Jun 2025 07:00:00 GMT
• immune cell therapy market to witness comprehensive growth openPR.com Mon, 23 Jun 2025 07:00:00 GMT
• positive week for adaptimmune therapeutics plc (nasdaq:adap) institutional investors who lost 68% over the past year Yahoo Wed, 18 Jun 2025 12:30:00 GMT
• Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer GlobeNewswire Thu, 29 May 2025 07:00:00 GMT
• Context Therapeutics names new CMO to advance T cell therapies Investing.com Thu, 29 May 2025 07:00:00 GMT
• context therapeutics appoints dr. karen chagin, m.d. as chief medical officer citybiz Thu, 29 May 2025 07:00:00 GMT
• adaptimmune’s annual meeting focuses on shareholder engagement TipRanks Thu, 29 May 2025 07:00:00 GMT
• context therapeutics appoints developer of first fda-approved solid tumor cell therapy as chief medical officer Stock Titan Thu, 29 May 2025 07:00:00 GMT
• jonestrading maintains adaptimmune therapeutics(adap.us) with hold rating 富途牛牛 Tue, 27 May 2025 22:03:14 GMT
• hold rating for adaptimmune therapeutics amid strategic progress and financial uncertainties TipRanks Fri, 16 May 2025 07:00:00 GMT
• adaptimmune’s earnings call: success amid financial concerns TipRanks Fri, 16 May 2025 01:16:06 GMT
• Adaptimmune’s Earnings Call: Success Amid Financial Concerns TipRanks Thu, 15 May 2025 07:00:00 GMT
• scotiabank keeps their buy rating on adaptimmune therapeutics (adap) The Globe and Mail Thu, 15 May 2025 07:00:00 GMT
• cautious hold on adaptimmune therapeutics amid strategic developments and liquidity concerns TipRanks Thu, 15 May 2025 06:50:20 GMT
• adaptimmune price target lowered to $1 from $1.50 at wells fargo TipRanks Wed, 14 May 2025 15:00:58 GMT
• adaptimmune therapeutics plc reports q1 2025 revenue of $4 milli GuruFocus Wed, 14 May 2025 10:58:47 GMT
• adaptimmune price target lowered to 46c from $1 at barclays TipRanks Wed, 14 May 2025 09:33:25 GMT
• Adaptimmune Therapeutics PLC (ADAP) Q1 2025 Earnings Call Highlights: Strong Tecelra Launch ... Yahoo Finance Wed, 14 May 2025 07:00:00 GMT
• promising growth prospects and strategic advancements drive buy rating for adaptimmune therapeutics TipRanks Wed, 14 May 2025 07:00:00 GMT
• forecasting the future: 6 analyst projections for adaptimmune therapeutics 富途牛牛 Wed, 14 May 2025 07:00:00 GMT
• adaptimmune therapeutics plc (nasdaq:adap) q1 2025 earnings call transcript Insider Monkey Wed, 14 May 2025 07:00:00 GMT
• barclays lowers price target for adaptimmune therapeutics (adap) | adap stock news GuruFocus Wed, 14 May 2025 07:00:00 GMT
• adaptimmune (adap) price target reduced amid balance sheet concerns | adap stock news GuruFocus Wed, 14 May 2025 07:00:00 GMT
• adaptimmune therapeutics (adap) sees price target reduction by w GuruFocus Wed, 14 May 2025 07:00:00 GMT
• barclays analyst adjusts price target for adaptimmune (adap) | a GuruFocus Wed, 14 May 2025 07:00:00 GMT
• adaptimmune therapeutics plc reports results for the quarter ended march 31 - earnings summary TradingView Wed, 14 May 2025 07:00:00 GMT
• adaptimmune reports q1 financial results and provides business u GuruFocus Wed, 14 May 2025 06:57:50 GMT
• adaptimmune targets $35m–$45m tecelra sales in 2025 as atc network nears completion MSN Tue, 13 May 2025 20:18:24 GMT
• what to expect from adaptimmune therapeutics plc (adap) q1 2025 earnings GuruFocus Tue, 13 May 2025 10:44:33 GMT
• ADAPTIMMUNE THERAPEUTICS Earnings Results: $ADAP Reports Quarterly Earnings Nasdaq Tue, 13 May 2025 07:00:00 GMT
• Adaptimmune Reports Q1 Financial Results and Provides Business Update Stock Titan Tue, 13 May 2025 07:00:00 GMT
• Adaptimmune Therapeutics earnings beat by $0.09, revenue fell short of estimates Investing.com Tue, 13 May 2025 07:00:00 GMT
• adaptimmune to report q1 2025 financial and business updates on tuesday, may 13, 2025 Newsfile Tue, 13 May 2025 07:00:00 GMT
• transcript : adaptimmune therapeutics plc, q1 2025 earnings call, may 13, 2025 MarketScreener Tue, 13 May 2025 07:00:00 GMT
• adaptimmune therapeutics plc reports q1 2025 revenue of $4 million, missing estimates; eps not provided GuruFocus Tue, 13 May 2025 07:00:00 GMT
• what to expect from adaptimmune therapeutics plc (adap) q1 2025 earnings GuruFocus Mon, 12 May 2025 07:00:00 GMT
• adaptimmune to report q1 2025 financial and business updates on tuesday, may 13, 2025 Newsfile Sun, 11 May 2025 20:28:33 GMT
• adaptimmune to report q1 2025 financial and business updates on tuesday, may 13, 2025 Newsfile Thu, 08 May 2025 04:05:48 GMT
• adaptimmune to report q1 2025 financial and business updates on tuesday, may 13, 2025 Yahoo Finance Wed, 07 May 2025 07:00:00 GMT
• adap - adaptimmune therapeutics plc latest stock news & market updates Stock Titan Sat, 03 May 2025 08:44:25 GMT
• milton park biotech firm receives designation for rare sarcoma therapy Insider Media Ltd Fri, 25 Apr 2025 07:00:00 GMT
• ADAP - Adaptimmune Therapeutics Plc Latest Stock News & Market Updates Stock Titan Fri, 25 Apr 2025 00:14:53 GMT
• repertoire and genentech to develop autoimmune disease therapies Pharmaceutical Technology Thu, 24 Apr 2025 07:00:00 GMT
• tcr therapy market future business opportunities 2025-2032 | adaptimmune therapeutics, alaunos therapeutics openPR.com Tue, 22 Apr 2025 14:13:00 GMT
• jonesresearch downgrades adaptimmune (adap) to hold amid capital concerns | adap stock news GuruFocus Sat, 12 Apr 2025 16:47:10 GMT
• adaptimmune therapeutics: hold rating amid financial uncertainties and strategic challenges TipRanks Fri, 11 Apr 2025 20:56:20 GMT
• jonesresearch downgrades adaptimmune (adap) to hold amid capital concerns | adap stock news GuruFocus Fri, 11 Apr 2025 07:00:00 GMT
• gene therapy market demand, growth and future scope 2025-2032 | openPR.com Fri, 04 Apr 2025 07:00:00 GMT
• finance watch: as stocks tumble, offerings slow, financial alternatives rise insights.citeline.com Thu, 03 Apr 2025 23:24:47 GMT
• synovial sarcoma treatment market size in 7mm is expected to grow openPR.com Wed, 02 Apr 2025 12:00:00 GMT
• h.c. wainwright cuts adaptimmune stock target to $3, maintains buy by investing.com Investing.com Canada Wed, 02 Apr 2025 06:26:32 GMT
• What Analysts Are Saying About Adaptimmune Therapeutics Stock Nasdaq Tue, 01 Apr 2025 07:00:00 GMT
• H.C. Wainwright cuts Adaptimmune stock target to $3, maintains Buy Investing.com Tue, 01 Apr 2025 07:00:00 GMT
• adaptimmune therapeutics plc (nasdaq:adap) q4 2024 earnings call transcript MSN Thu, 27 Mar 2025 18:45:23 GMT
• adap stock touches 52-week low at $0.22 amid sharp annual decline Investing.com Thu, 27 Mar 2025 07:00:00 GMT
• adaptimmune therapeutics: balancing positive momentum with strategic pauses – a hold rating analysis TipRanks Thu, 27 Mar 2025 07:00:00 GMT
• adaptimmune price target lowered to $1.75 from $3 at guggenheim TipRanks Thu, 27 Mar 2025 06:08:59 GMT
Adaptimmune Therapeutics plc(NASDAQ:ADAP) 
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to ide...
Website: http://www.adaptimmune.com
Full Time Employees: 420
Sector: Healthcare
Industry: Biotechnology